Definitive Healthcare Corp. experienced a slight revenue decline in 2025 driven by lower enterprise customer counts and sustained macroeconomic pressures that dampened sales execution. Despite a decrease in top-line to $241.5 million, the company generated positive operating cash flow and aggressively returned capital through share repurchases. Its SaaS platform remains differentiated by comprehensive healthcare data integration, supporting key verticals like life sciences and providers, while acquisitions such as Carevoyance and Populi remain central to expanding platform capabilities. Looking ahead, revenue is expected to soften further in 2026 due to current challenges, but opportunities exist in deepening existing client engagements and broadening use cases across healthcare stakeholders.